Skip to main content
Advertisement
Advertisement
ASMB
ASMB logo
Assembly Biosciences, Inc
21.12
USD
Sponsored
+0.94
+4.66%
Nov 13, 15:59 UTC -5
Closed
exchange

After-Market

21.34

+0.21
+1.02%

Assembly Biosciences, Inc (ASMB) Earnings

ASMB Earnings Reports

Positive Surprise Ratio

ASMB beat 28 of 40 last estimates.

70%

Next Report

Date of Next Report
Mar 17, 2027
Estimate for Q4 26 (Revenue/ EPS)
$4.89M
/
-$0.73
Implied change from Q3 26 (Revenue/ EPS)
--
/
--
Implied change from Q4 25 (Revenue/ EPS)
-88.49%
/
-129.44%

Assembly Biosciences, Inc earnings per share and revenue

On Nov 09, 2026, ASMB reported earnings of -- USD per share (EPS) for Q3 26, -- the estimate of -0.45 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 7.40 million, with a --% difference.
Looking ahead to Q4 26, -- analysts forecast an EPS of -0.73 USD, with revenue projected to reach 4.89 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Personalis, Inc. Common Stock
Report Date
Nov 04, 2026 For Q3 26
Estimate
-$0.25
Actual
-$0.32
Surprise
-24.08%
logo
Taysha Gene Therapies, Inc. Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.13
Actual
-$0.10
Surprise
+24.59%
logo
Amphastar Pharmaceuticals, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.87
Actual
$1.13
Surprise
+30.18%
logo
Sol-Gel Technologies Ltd. Ordinary Shares
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$2.11
Actual
-$1.72
Surprise
+18.67%
logo
Teva Pharmaceutical Industries Limited
Report Date
Nov 03, 2026 For Q3 26
Estimate
$0.74
Actual
$0.86
Surprise
+15.50%
logo
Metagenomi Therapeutics, Inc. Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.64
Actual
-$0.56
Surprise
+13.31%
FAQ
For Q3 2026, Assembly Biosciences, Inc reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
The next earning report is scheduled for Mar 17, 2027.
Based on -- analysts, Assembly Biosciences, Inc is expected to report EPS of -$0.73 and revenue of $4.89M for Q4 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement